奇士達(06918.HK)擬斥300萬元組合營數碼親子兒童主題樂園
奇士達(06918.HK)公布,附屬公司Kidztech Investment與誠彩發展訂立合營協議,雙方同意成立合營企業,在內地建設並營運涉及元宇宙元素的數碼親子兒童主題樂園。
合營企業的擬議名稱為奇士達華夏樂園有限公司。Kidztech Investment須向合營企業注資300萬元現金,並擁有合營企業51%股權。合營企業將被視為公司的附屬公司,其財務業績將併入公司的綜合財務報表。
誠彩發展須向合營企業透過提供使用華夏文化(01566.HK)所擁有的相關IP及有關經營涉及元宇宙元素的數碼兒童主題樂園的解決方案的授權、動畫相關IP、VR/AR技術及遊戲資產方式作出貢獻,並擁有合營企業49%股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.